Evidence map›Paper›PMID 34893542›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Molecular mechanism of glycolytic flux control intrinsic to human phosphoglycerate kinase.

Hiromasa Yagi, Takuma Kasai, Elisa Rioual, Teppei Ikeya, Takanori Kigawa

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Glycolysis enzymes and cellular lactylation in tumour.Clinical and translational medicine · 2026
    Review
  3. Review
  4. Glyceraldehyde-3-phosphate dehydrogenase homologs as bifunctional gatekeepers of metabolic segregation inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hiromasa YagiRIKEN Center for Biosystems Dynamics Research, Laboratory for Cellular Structural Biology, Yokohama 230-0045, Japan.ORCID 0000-0001-8059-4440
Takuma KasaiRIKEN Center for Biosystems Dynamics Research, Laboratory for Cellular Structural Biology, Yokohama 230-0045, Japan.ORCID 0000-0002-0089-533X
Elisa RioualRIKEN Center for Biosystems Dynamics Research, Laboratory for Cellular Structural Biology, Yokohama 230-0045, Japan.ORCID 0000-0003-2981-3454
Teppei IkeyaDepartment of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Tokyo 192-0397, Japan.
Takanori KigawaRIKEN Center for Biosystems Dynamics Research, Laboratory for Cellular Structural Biology, Yokohama 230-0045, Japan; kigawa@riken.jp.ORCID 0000-0003-0146-9719
RIKEN Center for Biosystems Dynamics Research · JPTokyo Metropolitan University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycolysis plays a fundamental role in energy production and metabolic homeostasis. The intracellular [adenosine triphosphate]/[adenosine diphosphate] ([ATP]/[ADP]) ratio controls glycolytic flux; however, the regulatory mechanism underlying reactions catalyzed by individual glycolytic enzymes enabling flux adaptation remains incompletely understood. Phosphoglycerate kinase (PGK) catalyzes the reversible phosphotransfer reaction, which directly produces ATP in a near-equilibrium step of glycolysis. Despite extensive studies on the transcriptional regulation of PGK expression, the mechanism in response to changes in the [ATP]/[ADP] ratio remains obscure. Here, we report a protein-level regulation of human PGK (hPGK) by utilizing the switching ligand-binding cooperativities between adenine nucleotides and 3-phosphoglycerate (3PG). This was revealed by nuclear magnetic resonance (NMR) spectroscopy at physiological salt concentrations. MgADP and 3PG bind to hPGK with negative cooperativity, whereas MgAMPPNP (a nonhydrolyzable ATP analog) and 3PG bind to hPGK with positive cooperativity. These opposite cooperativities enable a shift between different ligand-bound states depending on the intracellular [ATP]/[ADP] ratio. Based on these findings, we present an atomic-scale description of the reaction scheme for hPGK under physiological conditions. Our results indicate that hPGK intrinsically modulates its function via ligand-binding cooperativities that are finely tuned to respond to changes in the [ATP]/[ADP] ratio. The alteration of ligand-binding cooperativities could be one of the self-regulatory mechanisms for enzymes in bidirectional pathways, which enables rapid adaptation to changes in the intracellular environment.

Indexed as

Adenosine DiphosphateAdenosine TriphosphateCatalysisCatalytic DomainEscherichia coliGene Expression Regulation, EnzymologicGlyceric AcidsGlycolysisHumansModels, MolecularPhosphoglycerate KinaseProtein BindingProtein Conformation3-phosphoglycerateAdenosine DiphosphateAdenosine TriphosphateGlyceric AcidsPhosphoglycerate Kinaseenzyme regulationglycolysisin-cell NMRligand-binding cooperativitysolution NMR

Identifiers

PMID34893542
PMCPMC8685715
OpenAlexW4200465024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.